Skip to main content

Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (882)

Denosumab

Bone-Modifying Agent

Therapeutic Category

Bone-Modifying Agent

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

RANKL Inhibitor

Dabrafenib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

BRAF / MEK Inhibitor

Lenvatinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Solid Tumour

Drug Class / Mechanism

Multi-Kinase / Anti-Angiogenic Inhibitor

Lutetium-177 Vipivotide Tetraxetan

Radiopharmaceutical / Nuclear Medicine

Therapeutic Category

Radiopharmaceutical / Nuclear Medicine

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Radiotherapeutic / Radiodiagnostic Agent

Brentuximab Vedotin

Targeted Therapy (Antibody-Drug Conjugate)

Therapeutic Category

Targeted Therapy (Antibody-Drug Conjugate)

Oncology Type

Hematologic

Drug Class / Mechanism

ADC

Cetuximab

Targeted Therapy (Antibody)

Therapeutic Category

Targeted Therapy (Antibody)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Anti-EGFR mAb

Ciltacabtagene Autoleucel

Cellular Therapy (CAR-T)

Therapeutic Category

Cellular Therapy (CAR-T)

Oncology Type

Hematologic (Leukemia/Lymphoma/Myeloma)

Drug Class / Mechanism

Chimeric Antigen Receptor T-Cell Therapy

Enfortumab Vedotin

Targeted Therapy (Antibody-Drug Conjugate)

Therapeutic Category

Targeted Therapy (Antibody-Drug Conjugate)

Oncology Type

Solid Tumour

Drug Class / Mechanism

ADC

Polatuzumab Vedotin

Targeted Therapy (Antibody-Drug Conjugate)

Therapeutic Category

Targeted Therapy (Antibody-Drug Conjugate)

Oncology Type

Hematologic

Drug Class / Mechanism

ADC

Axicabtagene Ciloleucel

Cellular Therapy (CAR-T)

Therapeutic Category

Cellular Therapy (CAR-T)

Oncology Type

Hematologic (Leukemia/Lymphoma/Myeloma)

Drug Class / Mechanism

Chimeric Antigen Receptor T-Cell Therapy

Lisocabtagene Maraleucel

Cellular Therapy (CAR-T)

Therapeutic Category

Cellular Therapy (CAR-T)

Oncology Type

Hematologic (Leukemia/Lymphoma/Myeloma)

Drug Class / Mechanism

Chimeric Antigen Receptor T-Cell Therapy

Sacituzumab Govitecan

Targeted Therapy (Antibody-Drug Conjugate)

Therapeutic Category

Targeted Therapy (Antibody-Drug Conjugate)

Oncology Type

Solid Tumour

Drug Class / Mechanism

ADC